Deletions of CDKN2C in Multiple Myeloma: Biological and Clinical Implications

PURPOSE: Deletions of chromosome 1 have been described in 7-40% of cases of myeloma with inconsistent clinical consequences. CDKN2C at 1p32.3 has been identified in myeloma cell lines as the potential target of the deletion. We tested the clinical impact of 1p deletion and used high resolution techn...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Leone, Paola E., Walker, Brian A., Jenner, Matthew W., Chiecchio, Laura, Dagrada, GianPaolo, Protheroe, Rebecca K.M., Johnson, David C., Dickens, Nicholas J., Brito, Jose Luis, Else, Monica, Gonzalez, David, Ross, Fiona M., Chen-Kiang, Selina, Davies, Faith E., Morgan, Gareth J.
Format: Artigo
Langue:Inglês
Publié: 2008
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2581792/
https://ncbi.nlm.nih.gov/pubmed/18829482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-08-0347
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires